Extent of use and compliance to biophosphonates in the medical management of osteoporosis: an observational pilot study in a managed care organization

dc.contributor.author	Maluleke, Tirhani Lineth
dc.date.accessioned	2014-02-18T06:13:37Z
dc.date.available	2014-02-18T06:13:37Z
dc.date.issued	2013
dc.description	Research report presented to the department Pharmacy and Pharmacology of the University of the Witwatersrand in partial fulfillment of the requirements of the Masters of Science in Pharmaceutical Affairs, University of the Witwatersrand, 20 February 2013	en_ZA
dc.description.abstract	The current study was a retrospective observational pilot study designed to assess compliance to bisphosphonates treatment by patients diagnosed with osteoporosis (between 01 January 2010 and 17 August 2011). In this study, the cost of pharmacological agents used in the chronic medical management of osteoporosis was also estimated. The total number of patients whose records were eligible for analysis was 286, with the mean age of 66.7 years. The majority of patient's records (91%) were for females
dc.identifier.uri	http://hdl.handle.net10539/13799
dc.language.iso	en	en_ZA
dc.subject.mesh	Osteoporosis
dc.subject.mesh	Diphosphonates
dc.title	Extent of use and compliance to biophosphonates in the medical management of osteoporosis: an observational pilot study in a managed care organization	en_ZA
dc.type	Thesis	en_ZA

Files

Now showing 1 - 1 of 1

Name:: 2013-02-28- Extent of Use and Compliance to Bisphosphonates in the Medical Management of OP - Final Submission.pdf
Size:: 19.02 MB
Format:: Adobe Portable Document Format

Now showing 1 - 1 of 1